GammaDelta Therapeutics
Latest round
- Seed
Last raised
- Aug 2016
Total raised
- $1M
Investors
- 4
About GammaDelta Therapeutics
GammaDelta Therapeutics Ltd.Founded in 2016, GammaDelta Therapeutics Ltd. is based in London, UK, and focuses on developing novel therapies utilizing gamma delta T cells. The company was acquired by Takeda Pharmaceutical Company Limited in October 2021, a strategic move aimed at enhancing their therapeutic offerings. The CEO is Paolo Paoletti, and the founder is Adrian Hayday, who has a notable history in immunology and cell therapy.GammaDelta Therapeutics offers a range of cell therapy products focused on utilizing gamma delta T cells for cancer treatment. Their innovative therapies are at the forefront of immunotherapy, targeting various malignancies and advancing research in the oncology field.18 mn.GammaDelta Therapeutics is committed to expanding its product pipeline with upcoming therapies aimed at treating various cancers, with specific launch dates yet to be announced.00 mn to support these initiatives. The acquisition by Takeda is expected to enhance their capabilities and expedite the development of their therapeutic offerings.
Who invested in GammaDelta Therapeutics
4 investors across 1 round
See all investors in GammaDelta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 15, 2016
Amount
$1M
Investors
Questions about GammaDelta Therapeutics
Who invested in GammaDelta Therapeutics?
GammaDelta Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GammaDelta Therapeutics raised?
GammaDelta Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GammaDelta Therapeutics last raise money?
GammaDelta Therapeutics's most recent round on record is a Seed, in Aug 2016.
What does GammaDelta Therapeutics do?
GammaDelta Therapeutics is a biotechnology company.
Where is GammaDelta Therapeutics headquartered?
GammaDelta Therapeutics is headquartered in London, UK.
Which VCs invest in companies like GammaDelta Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at GammaDelta Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like GammaDelta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.